In DMP1-treated mice with advanced CKD, the dramatic elevations of circulating FGF23 levels are partially corrected despite increased and unchanged Fgf23 transcription, which suggests that DMP1 may also regulate FGF23 post-translational processing in CKD. Here, FGF23 is linked to chronic kidney disease.